Regeneron Pharmaceuticals has produced enough supply of its antibody drug to treat 50,000 patients. "Antibody Drugs Touted by Trump Could Be Next to Get Authorized for Covid-19" at 5:30 a.m. ET, incorrectly said it has enough supply to treat 30,000 patients.

 

(END) Dow Jones Newswires

October 09, 2020 10:54 ET (14:54 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Eli Lilly Charts.